304 related articles for article (PubMed ID: 14662775)
1. Ectopic expression of bovine type 5 phosphodiesterase confers a renal phenotype in Drosophila.
Broderick KE; Kean L; Dow JA; Pyne NJ; Davies SA
J Biol Chem; 2004 Feb; 279(9):8159-68. PubMed ID: 14662775
[TBL] [Abstract][Full Text] [Related]
2. A novel role for a Drosophila homologue of cGMP-specific phosphodiesterase in the active transport of cGMP.
Day JP; Houslay MD; Davies SA
Biochem J; 2006 Jan; 393(Pt 2):481-8. PubMed ID: 16232123
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
Turko IV; Ballard SA; Francis SH; Corbin JD
Mol Pharmacol; 1999 Jul; 56(1):124-30. PubMed ID: 10385692
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: its orientation impacts cGMP but not cAMP affinity.
Zoraghi R; Corbin JD; Francis SH
J Biol Chem; 2006 Mar; 281(9):5553-8. PubMed ID: 16407275
[TBL] [Abstract][Full Text] [Related]
5. Interactions between epithelial nitric oxide signaling and phosphodiesterase activity in Drosophila.
Broderick KE; MacPherson MR; Regulski M; Tully T; Dow JA; Davies SA
Am J Physiol Cell Physiol; 2003 Nov; 285(5):C1207-18. PubMed ID: 12853288
[TBL] [Abstract][Full Text] [Related]
6. Expression of an active, monomeric catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5).
Fink TL; Francis SH; Beasley A; Grimes KA; Corbin JD
J Biol Chem; 1999 Dec; 274(49):34613-20. PubMed ID: 10574925
[TBL] [Abstract][Full Text] [Related]
7. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
[TBL] [Abstract][Full Text] [Related]
8. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
[TBL] [Abstract][Full Text] [Related]
9. Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum.
Gopal VK; Francis SH; Corbin JD
Eur J Biochem; 2001 Jun; 268(11):3304-12. PubMed ID: 11389733
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.
Wallis RM; Corbin JD; Francis SH; Ellis P
Am J Cardiol; 1999 Mar; 83(5A):3C-12C. PubMed ID: 10078537
[TBL] [Abstract][Full Text] [Related]
11. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra).
Bouley R; Pastor-Soler N; Cohen O; McLaughlin M; Breton S; Brown D
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1103-12. PubMed ID: 15644488
[TBL] [Abstract][Full Text] [Related]
13. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.
Castro LR; Verde I; Cooper DM; Fischmeister R
Circulation; 2006 May; 113(18):2221-8. PubMed ID: 16651469
[TBL] [Abstract][Full Text] [Related]
14. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
[TBL] [Abstract][Full Text] [Related]
15. Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain.
Giordano D; De Stefano ME; Citro G; Modica A; Giorgi M
Biochim Biophys Acta; 2001 May; 1539(1-2):16-27. PubMed ID: 11389965
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
Corbin JD; Francis SH; Webb DJ
Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
[TBL] [Abstract][Full Text] [Related]
18. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.
Ballard SA; Gingell CJ; Tang K; Turner LA; Price ME; Naylor AM
J Urol; 1998 Jun; 159(6):2164-71. PubMed ID: 9598563
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig.
Kruuse C; Khurana TS; Rybalkin SD; Birk S; Engel U; Edvinsson L; Olesen J
Eur J Pharmacol; 2005 Oct; 521(1-3):105-14. PubMed ID: 16182282
[TBL] [Abstract][Full Text] [Related]
20. Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.
Pauvert O; Lugnier C; Keravis T; Marthan R; Rousseau E; Savineau JP
Br J Pharmacol; 2003 Jun; 139(3):513-22. PubMed ID: 12788811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
